$MGNX
MACROGENICS INC Stock $mgnx

$mgnx Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000112534518000058 Filed on May 07, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$4.695M	$2.055M
YoY Change	128.47%	-27.79%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$9.200M	$7.500M
YoY Change	22.67%	22.95%
% of Gross Profit
Research & Development	$45.67M	$32.80M
YoY Change	39.23%	19.95%
% of Gross Profit
Depreciation & Amortization	$1.338M	$1.978M
YoY Change	-32.36%	11.69%
% of Gross Profit
Operating Expenses	$45.67M	$32.80M
YoY Change	39.23%	19.95%
Operating Profit	-$50.21M	-$38.21M
YoY Change	31.41%	24.73%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$674.0K	$553.0K
YoY Change	21.88%	104.81%
Pretax Income	-$49.50M	-$37.70M
YoY Change	31.3%	24.01%
Income Tax
% Of Pretax Income
Net Earnings	-$49.54M	-$37.66M
YoY Change	31.55%	24.02%
Net Earnings / Revenue	-1055.08%	-1832.36%
Basic Earnings Per Share		-$1.08
Diluted Earnings Per Share	-$1.341M	-$1.08
COMMON SHARES
Basic Shares Outstanding	36.94M shares	34.96M shares
Diluted Shares Outstanding	36.94M shares	34.96M shares

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$260.1M	$243.1M
YoY Change	6.99%	-20.14%
Cash & Equivalents	$200.4M	$40.52M
Short-Term Investments	$59.60M	$202.6M
Other Short-Term Assets	$3.600M	$5.800M
YoY Change	-37.93%	152.17%
Inventory
Prepaid Expenses	$3.328M	$5.018M
Receivables	$7.281M	$2.093M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$271.0M	$251.0M
YoY Change	7.98%	-18.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$53.44M	$17.38M
YoY Change	207.57%	21.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$5.000M
YoY Change
Other Assets	$1.596M	$1.360M
YoY Change	17.35%	-32.0%
Total Long-Term Assets	$55.04M	$23.71M
YoY Change	132.09%	44.6%
TOTAL ASSETS
Total Short-Term Assets	$271.0M	$251.0M
Total Long-Term Assets	$55.04M	$23.71M
Total Assets	$326.1M	$274.7M
YoY Change	18.69%	-15.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.27M	$1.515M
YoY Change	577.62%	37.73%
Accrued Expenses	$30.49M	$17.96M
YoY Change	69.79%	85.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$1.500M
YoY Change	-100.0%	-28.57%
Total Short-Term Liabilities	$49.96M	$26.55M
YoY Change	88.14%	49.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$28.80M	$13.50M
YoY Change	113.33%	-30.77%
Total Long-Term Liabilities	$28.80M	$13.50M
YoY Change	113.33%	-37.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$49.96M	$26.55M
Total Long-Term Liabilities	$28.80M	$13.50M
Total Liabilities	$78.80M	$40.08M
YoY Change	96.6%	1.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$318.8M	-$330.4M
YoY Change	-3.5%
Common Stock	$615.7M	$565.1M
YoY Change	8.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$247.3M	$234.6M
YoY Change
Total Liabilities & Shareholders Equity	$326.1M	$274.7M
YoY Change	18.69%	-15.65%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$49.54M	-$37.66M
YoY Change	31.55%	24.02%
Depreciation, Depletion And Amortization	$1.338M	$1.978M
YoY Change	-32.36%	11.69%
Cash From Operating Activities	-$31.30M	-$35.33M
YoY Change	-11.41%	10.72%
INVESTING ACTIVITIES
Capital Expenditures	$14.52M	$1.492M
YoY Change	873.12%	-47.3%
Acquisitions
YoY Change
Other Investing Activities	$33.91M	-$6.870M
YoY Change	-593.6%	-29.18%
Cash From Investing Activities	$19.39M	-$8.360M
YoY Change	-331.94%	-33.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	630.0K	110.0K
YoY Change	472.73%	-50.0%
NET CHANGE
Cash From Operating Activities	-31.30M	-35.33M
Cash From Investing Activities	19.39M	-8.360M
Cash From Financing Activities	630.0K	110.0K
Net Change In Cash	-11.28M	-43.58M
YoY Change	-74.12%	-1.45%
FREE CASH FLOW
Cash From Operating Activities	-$31.30M	-$35.33M
Capital Expenditures	$14.52M	$1.492M
Free Cash Flow	-$45.82M	-$36.82M
YoY Change	24.43%	5.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001125345
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42202078	shares
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	MACROGENICS INC
CY2018Q1	mgnx	Contract With Customer Liability Increasefrom Cash Receipts ContractWithCustomerLiabilityIncreasefromCashReceipts	500000	USD
CY2017Q1	mgnx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-326000	USD
CY2018Q1	mgnx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-312000	USD
CY2017Q1	mgnx	Proceedsfrom Stock Options Exercised And Espp Purchases ProceedsfromStockOptionsExercisedAndESPPPurchases	108000	USD
CY2018Q1	mgnx	Proceedsfrom Stock Options Exercised And Espp Purchases ProceedsfromStockOptionsExercisedAndESPPPurchases	629000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2451000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10266000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13643000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7281000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38581000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30489000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-61000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-23000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	611270000	USD
CY2018Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	615284000	USD
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4743518	shares
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5315477	shares
CY2017Q4	us-gaap	Assets Assets	373883000	USD
CY2018Q1	us-gaap	Assets Assets	326078000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	322298000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	271039000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	63000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	27000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	93455000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	59656000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	93394000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	59633000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84098000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40518000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	211727000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	200448000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-43580000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-11279000	USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36859077	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37024623	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	369000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	370000	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	27318000	USD
CY2018Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	25883000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1935000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1900000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	40263000	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	54905000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	1048000	USD
CY2018Q1	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	905000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	11253000	USD
CY2018Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	11084000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7202000	USD
CY2018Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8121000	USD
CY2018Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7742000	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	13637000	USD
CY2018Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	17762000	USD
CY2018Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	19576000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1978000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1338000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.08
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.34
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	34500000	USD
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7462000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9235000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2223000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	49755000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	49956000	USD
CY2017Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	1278000	USD
CY2018Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	4501000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	7815000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-671000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6361000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1823000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1477000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1065000	USD
CY2018Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1435000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	81000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-40000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1535000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	177000	USD
CY2017Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-379000	USD
CY2018Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-298000	USD
CY2017Q4	us-gaap	Investments Investments	93394000	USD
CY2018Q1	us-gaap	Investments Investments	59633000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	74645000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	78802000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	373883000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	326078000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	108000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	629000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-8357000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	19387000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-35331000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31295000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-37655000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-49536000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-38208000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-50210000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	383000	USD
CY2018Q1	us-gaap	Other Assets OtherAssets	349000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1602000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1596000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-26000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	39000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-37681000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-49497000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	175000	USD
CY2018Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	175000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	553000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	674000	USD
CY2017	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2018Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2018Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	298000	USD
CY2017Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	56937000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	24452000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1492000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14519000	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3151000	USD
CY2018Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3328000	USD
CY2017Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	50072000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	58358000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	600000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49983000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53443000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32801000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45670000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	298000	USD
CY2018Q1	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2017Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	298000	USD
CY2018Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-312340000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-368355000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-318819000	USD
CY2017Q1	us-gaap	Revenue From Grants RevenueFromGrants	777000	USD
CY2018Q1	us-gaap	Revenue From Grants RevenueFromGrants	194000	USD
CY2017Q1	us-gaap	Revenues Revenues	2055000	USD
CY2018Q1	us-gaap	Revenues Revenues	4695000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3461000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3432000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2940789	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.61
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3600000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	51423	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1038874	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.75
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	29749000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4504642	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5315477	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.79
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.97
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	29334000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5074332	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	21.76
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.03
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	20.90
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	28.49
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	25431000	USD
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y4M24D
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3300000	USD
CY2018Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	176616	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	299238000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	247276000	USD
CY2017Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2018Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34958228	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36936560	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34958228	shares
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	36936560	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34958228	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36936560	shares

Files In Submission

Name	View Source	Status
0001125345-18-000058-index-headers.html	Edgar Link	pending
0001125345-18-000058-index.html	Edgar Link	pending
0001125345-18-000058.txt	Edgar Link	pending
0001125345-18-000058-xbrl.zip	Edgar Link	pending
exhibit101incyteamendment.htm	Edgar Link	pending
exhibit31-1q12018.htm	Edgar Link	pending
exhibit31-2q12018.htm	Edgar Link	pending
exhibit32-1q12018.htm	Edgar Link	pending
exhibit32-2q12018.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mgnx-033118x10q.htm	Edgar Link	pending
mgnx-20180331.xml	Edgar Link	completed
mgnx-20180331.xsd	Edgar Link	pending
mgnx-20180331_cal.xml	Edgar Link	unprocessable
mgnx-20180331_def.xml	Edgar Link	unprocessable
mgnx-20180331_lab.xml	Edgar Link	unprocessable
mgnx-20180331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MGNX
MACROGENICS INC Stock $mgnx

2018 Q1 Form 10-Q Financial Statement

#000112534518000058 Filed on May 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGNX MACROGENICS INC Stock $mgnx

2018 Q1 Form 10-Q Financial Statement

#000112534518000058 Filed on May 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGNX
MACROGENICS INC Stock $mgnx